Hypothesis: does propranolol afford protection against atherosclerosis?
Namazi, M.R.
Nigerian Journal of Medicine Journal of the National Association of Resident Doctors of Nigeria 18(3): 339
2009
ISSN/ISBN: 1115-2613 PMID: 20120660 Document Number: 633822
Document emailed within 1 workday
Related Documents
Yamada, N. 2011: Atherosclerosis from the point of view of hypothesis to evidence based medicine Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 7-12Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353
Hickman, J.A.; Mottram, D.R.; Kidman, C. 1977: Comparative study of propranolol and dicyclohexylamine protection of alpha-receptor blockade Archives Internationales de Pharmacodynamie et de Therapie 228(2): 191-195
Lucas, S.K.; Magee, P.G.; Flaherty, J.T.; Gott, V.L.; Gardner, T.J. 1979: Additive myocardial protection during ischemic arrest with propranolol and potassium cardioplegia Surgical Forum 30: 257-260
Skjaerlund, J.M. 1992: Estrogen protection against atherosclerosis and synthetic estrogen production of cirrhosis in the rabbit Research Communications in Chemical Pathology and Pharmacology 75(2): 193-208
Pritchard, M.A.; Kola, I. 1999: The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in down syndrome Journal of Neural Transmission. Supplementum 57: 293-303
Wakabayashi, K. 1990: International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/3. Animal studies suggesting involvement of mutagen/carcinogen exposure in atherosclerosis Mutation Research 239(3): 181-187
Murakami, E.; Shiosaka, S.; Tohyama, M. 1981: Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors? Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Charbit, J.; Greenberg, R.S. 1979: "I can't afford a 'B'" New England Journal of Medicine 301(11): 616
Curtis, A. 1983: A luxury we cannot afford? Nursing Times 79(28): 11-13
Friedman, J.H. 2003: We can't afford to see patients Medicine and Health Rhode Island 86(6): 158
Seitsalo, S.; Roine, R. 2000: Can we afford operations? Duodecim; Laaketieteellinen Aikakauskirja 116(19): 2053-2054
Shuttleworth, A. 1992: An export trend we can ill afford Professional Nurse 8(1): 4
Berglin, L. 2010: An opportunity we cannot afford to lose Minnesota Medicine 93(8): 30-32
Miranda, F.J. 1985: Your drug license: can you afford to practice without it? Journal - Oklahoma Dental Association 76(2): 21-24
Hussey, G.; Robertson, A.; Beatty, D. 1992: Children with AIDS--can we afford to treat them? South African Medical Journal 81(2): 61-62
Caplan, H. 1982: We can't afford to prolong so many hopeless lives Medical Economics 59(26): 62-66
Koska, M.T. 1991: Patient-centered care: can you afford not to have it? Trustee: the Journal for Hospital Governing Boards 44(1): 16-17